Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid rebates 1991

Executive Summary

Glaxo reports paying Medicaid rebates of $60 mil. during second half of calendar 1991. If the company's payments in the first six months were at a similar level, it may well have rebated over $100 mil. to the state and federal governments in 1991. The total rebates for 1991 have been estimated in the $570 mil. range. Glaxo may be paying around 20% of the rebates. By comparison, Bristol-Myers Squibb paid rebates of $55 mil. in 1991; Pfizer $44 mil., Merck approximately $30-$35 mil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS020527

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel